Literature DB >> 25398421

68Ga-NOTA-exendin-4 PET/CT in detection of occult insulinoma and evaluation of physiological uptake.

Yaping Luo1, Miao Yu, QingQing Pan, Wenming Wu, Taiping Zhang, Dale O Kiesewetter, Zhaohui Zhu, Fang Li, Xiaoyuan Chen, Yupei Zhao.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25398421      PMCID： PMC5223098          DOI： 10.1007/s00259-014-2946-9

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  5 in total

1.  GLP-1 receptor expression in human tumors and human normal tissues: potential for in vivo targeting.

Authors:  Meike Körner; Martin Stöckli; Beatrice Waser; Jean Claude Reubi
Journal:  J Nucl Med       Date:  2007-05       Impact factor: 10.057

2.  Glucagon-like peptide-1 receptor imaging for localization of insulinomas.

Authors:  Emanuel Christ; Damian Wild; Flavio Forrer; Michael Brändle; Rahel Sahli; Thomas Clerici; Beat Gloor; Ferdinand Martius; Helmut Maecke; Jean Claude Reubi
Journal:  J Clin Endocrinol Metab       Date:  2009-10-09       Impact factor: 5.958

3.  Detection of metastatic insulinoma by positron emission tomography with [(68)ga]exendin-4-a case report.

Authors:  Olof Eriksson; Irina Velikyan; Ram K Selvaraju; Fouad Kandeel; Lars Johansson; Gunnar Antoni; Barbro Eriksson; Jens Sörensen; Olle Korsgren
Journal:  J Clin Endocrinol Metab       Date:  2014-02-10       Impact factor: 5.958

4.  Glucagon-like peptide-1 receptor overexpression in cancer and its impact on clinical applications.

Authors:  Meike Körner; Emanuel Christ; Damian Wild; Jean Claude Reubi
Journal:  Front Endocrinol (Lausanne)       Date:  2012-12-06       Impact factor: 5.555

5.  Glucagon-like peptide-1 receptor imaging with [Lys40(Ahx-HYNIC- 99mTc/EDDA)NH2]-exendin-4 for the detection of insulinoma.

Authors:  Anna Sowa-Staszczak; Dorota Pach; Renata Mikołajczak; Helmut Mäcke; Agata Jabrocka-Hybel; Agnieszka Stefańska; Monika Tomaszuk; Barbara Janota; Aleksandra Gilis-Januszewska; Maciej Małecki; Grzegorz Kamiński; Aldona Kowalska; Jan Kulig; Andrzej Matyja; Czesław Osuch; Alicja Hubalewska-Dydejczyk
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-12-07       Impact factor: 9.236
  5 in total
  13 in total

Review 1.  The functioning side of the pancreas: a review on insulinomas.

Authors:  I Maggio; V Mollica; N Brighi; G Lamberti; L Manuzzi; A D Ricci; D Campana
Journal:  J Endocrinol Invest       Date:  2019-07-31       Impact factor: 4.256

Review 2.  Advancement in treatment and diagnosis of pancreatic cancer with radiopharmaceuticals.

Authors:  Yu-Ping Xu; Min Yang
Journal:  World J Gastrointest Oncol       Date:  2016-02-15

Review 3.  Molecular imaging of β-cells: diabetes and beyond.

Authors:  Weijun Wei; Emily B Ehlerding; Xiaoli Lan; Quan-Yong Luo; Weibo Cai
Journal:  Adv Drug Deliv Rev       Date:  2018-07-03       Impact factor: 15.470

4.  Insulinoma-Accurate Preoperative Localization Is the Key to Management: An Initial Experience.

Authors:  Ajay Sharma; Peeyush Varshney; Rajeev Kasliwal; Anand Nagar; Krishnavardhan Venkatatelikicherla; Shashwat Sarin; R P Choubey; V K Kapoor
Journal:  Indian J Surg Oncol       Date:  2022-04-26

5.  Fully automated GMP production of [68Ga]Ga-DO3A-VS-Cys40-Exendin-4 for clinical use.

Authors:  Irina Velikyan; Ulrika Rosenstrom; Olof Eriksson
Journal:  Am J Nucl Med Mol Imaging       Date:  2017-07-15

6.  Glucagon-Like Peptide-1 Receptor PET/CT with 68Ga-NOTA-Exendin-4 for Detecting Localized Insulinoma: A Prospective Cohort Study.

Authors:  Yaping Luo; Qingqing Pan; Shaobo Yao; Miao Yu; Wenming Wu; Huadan Xue; Dale O Kiesewetter; Zhaohui Zhu; Fang Li; Yupei Zhao; Xiaoyuan Chen
Journal:  J Nucl Med       Date:  2016-01-21       Impact factor: 10.057

7.  68Ga-NOTA-Exendin-4 PET/CT in Localization of an Occult Insulinoma and Appearance of Coexisting Esophageal Carcinoma.

Authors:  Yaping Luo; Naishi Li; Dale O Kiesewetter; Xiaoyuan Chen; Fang Li
Journal:  Clin Nucl Med       Date:  2016-04       Impact factor: 7.794

8.  Radioiodinated Exendin-4 Is Superior to the Radiometal-Labelled Glucagon-Like Peptide-1 Receptor Probes Overcoming Their High Kidney Uptake.

Authors:  Tilman Läppchen; Roswitha Tönnesmann; Jos Eersels; Philipp T Meyer; Helmut R Maecke; Svetlana N Rylova
Journal:  PLoS One       Date:  2017-01-19       Impact factor: 3.240

Review 9.  Current Status of Radiopharmaceuticals for the Theranostics of Neuroendocrine Neoplasms.

Authors:  Melpomeni Fani; Petra Kolenc Peitl; Irina Velikyan
Journal:  Pharmaceuticals (Basel)       Date:  2017-03-15

Review 10.  Exendin-4 analogs in insulinoma theranostics.

Authors:  Tom J P Jansen; Sanne A M van Lith; Marti Boss; Maarten Brom; Lieke Joosten; Martin Béhé; Mijke Buitinga; Martin Gotthardt
Journal:  J Labelled Comp Radiopharm       Date:  2019-08       Impact factor: 1.921
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.